Cart
sales@molnova.com
Puliginurad
CAS No. 2013582-27-7
Puliginurad( —— )
Catalog No. M35505 CAS No. 2013582-27-7
Puliginurad (YL-90148) is a potent and selective inhibitor of the urate transporter protein (URAT), effectively inhibiting uric acid reabsorption. It can be utilized for the prevention and treatment of hyperuricemia and gout.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 93 | Get Quote |
|
| 5MG | 140 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePuliginurad
-
NoteResearch use only, not for human use.
-
Brief DescriptionPuliginurad (YL-90148) is a potent and selective inhibitor of the urate transporter protein (URAT), effectively inhibiting uric acid reabsorption. It can be utilized for the prevention and treatment of hyperuricemia and gout.
-
DescriptionPuliginurad (YL-90148) is a potent urate transporter (URAT) inhibitor. Puliginurad can be used for hyperuricemia and gout research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOAT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2013582-27-7
-
Formula Weight336.41
-
Molecular FormulaC19H16N2O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 130 mg/mL (386.43 mM; Ultrasonic )
-
SMILESC(C(C(O)=O)(C)C)C1=CC2=C(C=NC=C2S1)C3=CC=C(C#N)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. WHO Drug Information. International Nonproprietary Names for Pharmaceutical
molnova catalog
related products
-
IMR-1
IMR-1 is a novel class of Notch inhibitors targeting the transcriptional activation with IC50 of 6 μMol/L.
-
Recainam
Recainam is a novel, orally available compound with potent class I antiarrhythmic activity.
-
Sesamoside
Sesamoside has antinociceptive activity.
